Homatrapar 2% Eye Drop
Product introduction
Homatrapar 2% Eye Drop is used before eye examinations and to treat an eye condition called uveitis. It acts by enlarging the pupil of the eyes and helps the doctor visualize the eye more closely. It reduces redness and swelling in the eyes after cataract surgery.
Homatrapar 2% Eye Drop is for external use only. Use it in the dose and duration as advised by the doctor. Refrain from touching the tip of the dropper to any surface to avoid contaminating the eye drops.
The common side effects include burning and stinging sensation immediately after application. These are usually temporary and resolve with time. Using Homatrapar 2% Eye Drop can make your eyes more sensitive to light. Thus, wear sunglasses to protect your eyes from sunlight and other bright lights. Avoid driving right after using this medicine as it may cause blurring of the vision.
Homatrapar 2% Eye Drop is for external use only. Use it in the dose and duration as advised by the doctor. Refrain from touching the tip of the dropper to any surface to avoid contaminating the eye drops.
The common side effects include burning and stinging sensation immediately after application. These are usually temporary and resolve with time. Using Homatrapar 2% Eye Drop can make your eyes more sensitive to light. Thus, wear sunglasses to protect your eyes from sunlight and other bright lights. Avoid driving right after using this medicine as it may cause blurring of the vision.
Uses of Homatrapar Eye Drop
- Eye examination
- Uveitis
How to use Homatrapar Eye Drop
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.
How Homatrapar Eye Drop works
Homatrapar 2% Eye Drop is used to dilate or enlarge the pupil of the eye so that the doctor can examine the back of the eyeball. It may also be used to reduce pain in certain eye conditions.
Safety advice
Alcohol
No interaction found/established
Pregnancy
CONSULT YOUR DOCTOR
Homatrapar 2% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Homatrapar 2% Eye Drop is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
To reduce the amount of Homatrapar 2% Eye Drop that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
To reduce the amount of Homatrapar 2% Eye Drop that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Driving
CONSULT YOUR DOCTOR
It is not known whether Homatrapar 2% Eye Drop alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
No interaction found/established
Liver
No interaction found/established
What if you forget to take Homatrapar Eye Drop?
If you miss a dose of Homatrapar 2% Eye Drop, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Homatrapar 2% Eye Drop
₹20.9/Eye Drop
Homide Eye Drop
Indoco Remedies Ltd
₹33.6/eye drop
56% costlier
Homacid Eye Drop
Entod Pharmaceuticals Ltd
₹33/eye drop
53% costlier
Homarin Forte Eye Drop
Klar Sehen Pvt Ltd
₹31.9/eye drop
48% costlier
Homtask 2% Eye Drop
Akrovis Pharmaceuticals
₹33/eye drop
53% costlier
Homat 2% Eye Drop
Pharmatak Opthalmics Pvt Ltd
₹30/eye drop
39% costlier
Quick tips
- It is also used to relieve eye inflammation (redness and swelling) and infection.
- Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop.
- Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
- Stinging sensation may occur for 1-2 mins. Notify your doctor if it persists for longer.
- Make sure to use within 4 weeks of opening the bottle.
Fact Box
Chemical Class
Monocarboxylic Acid
Habit Forming
No
Therapeutic Class
OPHTHAL
Action Class
Mydriatic and Cycloplegic Anticholinergics
Interaction with drugs
Taking Homatrapar with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Talk to your doctor if you notice any unusual symptoms.
Concurrent use may cause dry mouth, blurred vision, urinary retention, constipation, and confusion.
Talk to your doctor if you notice any unusual symptoms.
Concurrent use may cause dry mouth, blurred vision, urinary retention, constipation, and confusion.
Talk to your doctor if you notice any unusual symptoms.
Concurrent use may cause dry mouth, blurred vision, urinary retention, constipation, and confusion.
Patient concerns
User feedback
Patients taking Homatrapar 2% Eye Drop
Thrice A Day
40%
Four Times A *
20%
Twice A Day
20%
Once A Day
20%
*Four Times A Day
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Brown JH, Laiken N. Muscarinic Receptor Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 233.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 657-58.
Marketer details
Name: Biomedica International
Address: Industrial Complex, Humbran, Ludhiana-141110, Punjab
Country of origin: India
The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.
The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.
Lab tests offered by us
Related/Popular tests
₹20.9
Inclusive of all taxes
MRP₹21.6 3% OFF
5.0 ml in 1 bottle
SOLD OUT
Available options
Available option
Same salt composition:Homatropine (2% w/v)

Same salt composition

Verified by doctors

Popularly bought

Trusted quality
Why buy these from 1mg?
